Lataa...
Therapeutic potential of targeting metabotropic glutamate receptors for Parkinson’s disease
Parkinson’s disease (PD) is a progressive neurological disorder predominantly characterized by motor symptoms including bradykinesia and resting tremor. The gold standard of treatment for PD remains dopamine replacement therapy, which eventually fails due to continued progression of the disease and...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3603000/ https://ncbi.nlm.nih.gov/pubmed/23526920 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/nmt.12.6 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|